SNS 01 - MICROBIO Group
Alternative Names: SNS01 - MICROBIO GroupLatest Information Update: 28 Feb 2024
At a glance
- Originator MICROBIO Group
- Class Antineoplastics; Immunotherapies; Monoclonal antibodies
- Mechanism of Action Cell proliferation inhibitors; Cytokine inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Non-small cell lung cancer
Most Recent Events
- 28 Feb 2024 No recent reports of development identified for preclinical development in Non-small-cell-lung-cancer in Taiwan (Parenteral)